Eli Lilly and Co. (NYSE:LLY) short sellers added to their positions, with the latest report following the company’s Q3 2026 earnings release.
Short interest rose 3.64% to 7.21 million shares as of the Oct. 30 settlement date, from 6.96 million at the Oct. 15 report. That is 0.81% of the float, a 3.85% rise in short interest as a percent of float.
Short interest peaked at 7.89 million shares (0.89% of float) on Aug. 31, and the latest level is 8.62% below that peak. The company reported Q3 2026 results on Oct. 29; EPS came in at $7.48 against a $6.36 estimate.
| Settlement Date | Shares Short | % of Float | Days to Cover |
|---|---|---|---|
| Oct. 30, 2026 | 7.21M | 0.81% | 2.66 |
| Oct. 15, 2026 | 6.96M | 0.78% | 3.04 |
| Sept. 30, 2026 | 7.04M | 0.79% | 2.93 |
| Sept. 15, 2026 | 7.52M | 0.84% | 3.41 |
| Aug. 31, 2026 | 7.89M | 0.89% | 2.99 |
| Aug. 14, 2026 | 6.56M | 0.74% | 2.11 |
Days to cover is 2.66: based on average daily volume, that is how many days it would take short sellers to buy back their shares. Implied average daily volume is about 2.71 million shares, from 2.29 million at the prior report.
According to Benzinga Pro, the average short interest as a percent of float across the 25 peers that reported on the same settlement date is 4.37%, which means Eli Lilly has lower short interest than its peers on average.
| Company | Shares Short | % of Float | Days to Cover | Change vs. Prior |
|---|---|---|---|---|
| Eli Lilly (LLY) | 7.21M | 0.81% | 2.66 | +3.64% |
| Johnson & Johnson (NYSE:JNJ) | 17.07M | 0.79% | 2.41 | +1.80% |
| Merck & Co (NYSE:MRK) | 26.60M | 1.08% | 2.36 | -0.82% |
| Novartis (NYSE:NVS) | 4.52M | 0.24% | 1.89 | -19.15% |
| AstraZeneca (NYSE:AZN) | 3.03M | 0.20% | 1.00 | -7.65% |
Short interest counts shares sold short but not yet covered, and short selling is a bet that the price will fall; rising short interest can signal more bearish sentiment and falling short interest less, but it is not a forecast of the stock’s direction.
LLY Price Action: Eli Lilly shares were down 0.95% at $1418.00 on Tuesday. This is 3.88% below the 52-week high. The stock is up 0.03% since the Oct. 30 settlement date.
See Also: List of the most shorted stocks
This article was generated by Benzinga’s automated content engine and was reviewed by an editor.